Hubei Guangji Pharmaceutical Co., Ltd.

¥5.67As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000952Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (10.35%)
Div yield —
ROE (52.09%)
Drug Manufacturers (General)
Beta (5Y) 0.35
PE TTM —
TSR TTM (18.30%)
Mkt cap ¥1.950B
ROIC (8.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.21
9.54%
(39.46%)
Hold 12|6|3|6|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.07
0.08
0.08
18.82%
9.04%
4.19%
1.56%
Revenue¥M
145.9
143.3
141.9
142.3
5.16%
1.56%
1.92%
(0.87%)
Peers (US$292.4M)
Cap (US$)
PE
326.9M
189.3x
Capital
TTM
5Y
10Y
Leveragex
0.263
0.526
0.506
EBIT/Intx
0.922
0.519
0.439
Own earn%
80.96
(95.85)
(81.87)
Sh yield%
28.41
39.20
35.40
Owners
Insiders/Inst%
1.57
54.61
Short interest%
4.32
SBC / revenue%
0.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
22–25
$1 testx
0.0
Incr. ROIC%
1